NGLFINE vs VINEETLAB: Stock Comparison

NGL Fine-Chem Limited vs Vineet Laboratories Limited

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

NGL Fine-Chem Limited is the larger company by market capitalisation. NGL Fine-Chem Limited shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of NGL Fine-Chem Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, NGLFINE is more favourable on 10 of 10 scored metrics and VINEETLAB on 0These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NGLFINE is the larger company
₹2,008 Cr vs ₹73 Cr
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹-20.47
Dividend Yield
NGLFINE has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 11.05%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -68.8%
Qtr Profit Growth
NGLFINE has stronger quarterly profit growth
2,398% vs 59.2%
ROCE
NGLFINE has a higher ROCE
17% vs -28%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNGLFINEVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricNGLFINEVINEETLAB
Live Price₹3,260₹38.55
Day Change0.7%5.79%
Volume5,5952.02 L
52-Week High₹3,329₹49.99
52-Week Low₹1,175.5₹27.96
Distance from 52W High-2.07%-22.88%

Valuation

MetricNGLFINEVINEETLAB
Market Cap₹2,008 Cr₹73 Cr
P/E Ratio41.23x
P/B Ratio6.03x
EPS₹78.04₹-20.47
Book Value₹532.95₹15.84
Dividend Yield0.05%0%

Growth

MetricNGLFINEVINEETLAB
Revenue Growth (TTM YoY)57.2%11.05%
EPS Growth (TTM YoY)1,539.8%0%
Qtr Sales Growth57.1%-68.8%
Qtr Profit Growth2,398%59.2%

Profitability & Leverage

MetricNGLFINEVINEETLAB
ROE15.7%
ROCE17%-28%
Net Margin9.59%-26.92%
Operating Margin14.5%-22.4%
Debt to Equity0.33x2.73x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricNGLFINEVINEETLAB
Promoter Holding72.74%5.98% 6.48 pp
FII Holding0.03% 0.03 pp0.36% 0.36 pp
DII Holding0%
Public Holding27.24% 0.02 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL Fine-Chem Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.